首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Safety and efficacy of the percutaneous treatment of bile leaks in hepaticojejunostomy or split-liver transplantation without dilatation of the biliary tree
【24h】

Safety and efficacy of the percutaneous treatment of bile leaks in hepaticojejunostomy or split-liver transplantation without dilatation of the biliary tree

机译:经肝空肠造口术或肝不分割肝胆管造口术中经皮胆汁漏的经皮治疗的安全性和有效性

获取原文
获取原文并翻译 | 示例
           

摘要

Biliary leaks complicating hepaticojejunostomy (HJA) or fistulas from cut surface are severe complications after liver transplantation (LT) and split-liver transplantation (SLT). The aim of the study was to describe our experience about the safety and efficacy of radiological percutaneous treatment without dilatation of intrahepatic biliary ducts. From 1990 to 2006, 1595 LTs in 1463 patients were performed in our center. In 1199 LTs (75.2%), a duct-to-duct anastomosis was performed, and in 396 (24.8%), an HJA was performed. One hundred twenty-nine anastomotic or cut-surface bile leakages occurred in 115 patients. Sixty-two biliary leaks occurred in 54 patients with HJA; in 48 cases, an anastomotic fistula was found. Cut-surface fistulas occurred in 14 cases: 5 in right SLTs and 5 in left SLTs. Twenty-two patients were treated with 23 percutaneous approaches for 17 HJA fistulas and 6 cut-surface leaks without intrahepatic bile duct dilatation. Two percutaneous therapeutic approaches were used: percutaneous transhepatic biliary drainage (PTBD) for fistula alone and PTBD with percutaneous drainage of biliary collection in patients with both complications. PTBD was successful in 21 cases (91.3%); the median delay from catheter insertion and leak resolution was 10.3 days (range: 7-41). The median maintenance of drainage was 14.8 days. In 1 patient, fistula recurrence after PTBD needed a surgical approach; after that, an anastornotic fistula was still found, and a new PTBD was successfully performed. In another patient, PTBD was immediately followed by retransplantation for portal vein thrombosis. There were no complications related to the interventional procedure. In conclusion, biliary fistulas after HJA in LT or after SLT can be successfully treated by PTBD. The absence of enlarged intrahepatic biliary ducts should not be a contraindication for percutaneous treatment.
机译:胆道渗漏使肝空肠造口术(HJA)或切开瘘管的并发症变得复杂,是肝移植(LT)和剖肝移植(SLT)后的严重并发症。该研究的目的是描述我们在不进行肝内胆管扩张的情况下进行放射治疗的安全性和有效性的经验。从1990年到2006年,我们中心共对1463名患者进行了1595例LTs检查。在1199例LT(75.2%)中,进行了导管间吻合,在396例(24.8%)中,进行了HJA。 115名患者发生了129例吻合口或切开的胆汁泄漏。 54例HJA患者发生62例胆漏。在48例中,发现了吻合口瘘。切开瘘管发生在14例中:右侧SLT 5例,左侧SLT 5例。 22例患者接受了23例经皮入路治疗,治疗17例HJA瘘管和6例切开表面渗漏,无肝内胆管扩张症。使用了两种经皮治疗方法:对于两种并发症,仅对瘘管进行经皮肝穿刺胆道引流术(PTBD),对胆囊收集物进行经皮胆道引流术的PTBD。 PTBD成功21例(91.3%);插入导管和解决泄漏的中位延迟时间为10.3天(范围:7-41)。排水的中位维持时间为14.8天。在1例患者中,PTBD术后瘘管复发需要手术治疗;之后,仍发现了一个吻合口瘘,并成功进行了新的PTBD。在另一例患者中,PTBD立即被移植,以治疗门静脉血栓。没有与介入手术有关的并发症。总之,PTBD可以成功治疗LT或HLT后HJA后的胆道瘘。肝内胆管增大的情况不应该是经皮治疗的禁忌证。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号